Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)

pCPA File Number: 21069
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Obstructive Pulmonary Disease
Sponsor/Manufacturer:
GlaxoSmithKline
CADTH Project Number:
SR0562-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: